account_id none on file
legal_name Cadrenal Therapeutics, Inc.
ticker CVKD
cik 1937993
domain cadrenal.com
linkedin_company_url https://www.linkedin.com/company/cadrenal/
entry_point_account_id none on file
name Cadrenal Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 12 executives 8 family 0
why_nownone on file
callsnone on file
filings
Cash paid for the office lease was $ 14,085 and $ 13,313 for the three and six months ended June 30, 2026 and 2025, respectively.
filing / Aug 13, 2026 / receipt
In October 2025, the Company amended its office space lease to extend the term by one additional year. The lease agreement (as amended in October 2025) has a term that extends through October 31, 2026.
filing / Aug 13, 2026 / receipt
Sharp, Interim Chief Financial Officer John Sharp has served as our Interim Chief Financial Officer since June 2026. Mr.
filing / Aug 3, 2026 / receipt
This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies and intermediaries.
filing / Aug 3, 2026 / receipt
John R. Murphy has served on our Board of Directors since January 2023.
filing / Aug 3, 2026 / receipt
Dr. Lee Golden has served on our Board of Directors since November 2025.
filing / Aug 3, 2026 / receipt
Dr. Glynn Wilson has served on our Board of Directors since January 2023.
filing / Aug 3, 2026 / receipt
James Ferguson served as our Chief Medical Officer from February 2025 until his resignation, effective July 31, 2026.
filing / Aug 3, 2026 / receipt
Jeffrey Cole has served as our Chief Operating Officer since February 2024.
filing / Aug 3, 2026 / receipt
Quang X. Pham, Chairman and Chief Executive Officer
filing / Aug 3, 2026 / receipt
Matthew Szot, Former Chief Financial Officer
filing / Aug 3, 2026 / receipt
James J. Ferguson, Former Chief Medical Officer
filing / Aug 3, 2026 / receipt
executives
| Glynn Wilson | Director | - | receipt |
| James J. Ferguson | Former Chief Medical Officer | - | receipt |
| Jeffrey Cole | Chief Operating Officer | - | receipt |
| John P. Sharp | Interim Chief Financial Officer | - | receipt |
| John R. Murphy | Director | - | receipt |
| Lee Golden | Director | - | receipt |
| Matthew Szot | Chief Financial Officer and Co-Founder | receipt | |
| Quang X. Pham | Chairman and Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-09 | earnings call | scheduled | ir |
changes
| 2026-06-29 | Interim Chief Financial Officer, appointed | sec_8k |
| 2026-06-03 | Chief Executive Officer, appointed | sec_8k |
mcp_package_hint
slug cadrenal-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$